Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions

Emmerentia van Schalkwyk, K Strydom, Zelda Williams, Louis Venter, Stefan Leichtl, Christine Schmid-Wirlitsch, Dirk Bredenbroker, Philip G Bardin

Research output: Contribution to journalArticleResearchpeer-review

108 Citations (Scopus)
Original languageEnglish
Pages (from-to)292 - 298
Number of pages7
JournalThe Journal of Allergy and Clinical Immunology
Volume116
Issue number2
Publication statusPublished - 2005

Cite this